Muskulaskeletal Oncology Department, First Affiliated Hospital of Zhongshan University, Guangzhou, Guangdong, China.
Ann Surg Oncol. 2011 Jul;18(7):1852-9. doi: 10.1245/s10434-010-1443-z. Epub 2011 Feb 19.
The prognosis of humeral sarcomas has improved greatly in the past 20 years. As a result, the challenges for orthopedic oncologists include long-term handicap and local morbidity.
Shoulder reconstruction after the resection of sarcomas with the proximal humerus was evaluated for 55 patients from 1990 to 2007 at two universities. After S34(5)B resections (intra-articular resection of the proximal humerus and the abductor mechanism), the shoulders were reconstructed with arthrodesis, prosthesis, or allograft-prosthesis composites (APC).
At the time of the latest follow-up examination, the average duration of follow-up was 86.73 months for the 39 patients who were still alive and whose limbs were salvaged. The local recurrence rate was 7.27% (4 of 55). Functional evaluation was conducted on the 39 patients who had the postreconstructions: 12 arthrodeses, 17 prostheses, and 10 APC. Statistical analysis showed that the functional score of shoulder reconstruction significantly varied among the three groups by the test of homogeneity of variances with P = 0.222, by analysis of variance with P < 0.01, and by post hoc test (Student-Newman-Keuls) with α = 0.05. Primary arthrodesis resulted in better function and increased strength than the prostheses and the APC. Insertion of an allograft, a vascularized fibular graft, a rotational latissimus dorsi flap, and cancellous autograft bone were the preferred arthrodesis techniques used to achieve fusion and reduce complications.
After resection of the sarcoma with the proximal humerus with the abductor apparatus, shoulder arthrodesis is recommended above other reconstructions for better functional outcome as well as increased strength and capacity to position the hand.
在过去的 20 年中,肱骨肉瘤的预后有了很大的改善。因此,矫形肿瘤学家面临的挑战包括长期残疾和局部发病率。
在两所大学,对 1990 年至 2007 年期间接受近端肱骨肉瘤切除术的 55 名患者的肩部重建进行了评估。在 S34(5)B 切除(近端肱骨和外展肌机制的关节内切除)后,使用关节融合,假体或同种异体-假体复合物(APC)进行肩部重建。
在最新的随访检查时,仍有 39 名患者存活且肢体得以保留,其平均随访时间为 86.73 个月。局部复发率为 7.27%(55 例中有 4 例)。对进行了重建的 39 名患者进行了功能评估:12 例关节融合,17 例假体和 10 例 APC。方差齐性检验的方差分析表明,三组间的肩部重建功能评分存在显著差异,P = 0.222;通过方差分析,P < 0.01;通过事后检验(Student-Newman-Keuls),α = 0.05。初次关节融合的功能优于假体和 APC,且具有更高的强度和手的定位能力。为了实现融合并减少并发症,通常采用同种异体骨、带血管腓骨移植、旋转背阔肌皮瓣和松质骨自体骨进行关节融合。
在切除带有外展装置的近端肱骨肉瘤后,建议进行肩关节融合,以获得更好的功能结果以及更高的强度和手部定位能力,优于其他重建方法。